NCT01302834 · BASELINE

Baseline characteristics

Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer · Source last updated 2026-07-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

counts
group Id
BG000
value
406
group Id
BG001
value
399
group Id
BG002
value
805
units
Participants

groups

description
Intensity-modulated radiotherapy (IMRT) with concurrent cisplatin Cisplatin: 100 mg/m2 IV on days 1 and 22 of IMRT IMRT: 35 fractions over 6 weeks, 6 fractions per week, 2 Gray per fraction to total dose of 70 Gy.
id
BG000
title
IMRT + Cisplatin
description
Intensity-modulated radiotherapy (IMRT) with concurrent cetuximab Cetuximab: 400 mg/m2 IV 5-7 days before IMRT then 250 mg/m2 IV weekly for 7 weeks IMRT: 35 fractions over 6 weeks, 6 fractions per week, 2 Gray per fraction to total dose of 70 Gy.
id
BG001
title
IMRT + Cetuximab
description
Total of all reporting groups
id
BG002
title
Total

measures

classes
categories
measurements
group Id
BG000
lower Limit
52
upper Limit
63
value
58
group Id
BG001
lower Limit
52
upper Limit
63
value
58
group Id
BG002
lower Limit
52
upper Limit
63
value
58
dispersion Type
INTER_QUARTILE_RANGE
param Type
MEDIAN
title
Age, Continuous
unit Of Measure
years
classes
categories
measurements
group Id
BG000
value
344
group Id
BG001
value
345
group Id
BG002
value
689
title
<= 65
categories
measurements
group Id
BG000
value
62
group Id
BG001
value
54
group Id
BG002
value
116
title
> 65
param Type
COUNT_OF_PARTICIPANTS
title
Age, Customized
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
33
group Id
BG001
value
44
group Id
BG002
value
77
title
Female
measurements
group Id
BG000
value
373
group Id
BG001
value
355
group Id
BG002
value
728
title
Male
param Type
COUNT_OF_PARTICIPANTS
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
11
group Id
BG001
value
15
group Id
BG002
value
26
title
Hispanic or Latino
measurements
group Id
BG000
value
383
group Id
BG001
value
369
group Id
BG002
value
752
title
Not Hispanic or Latino
measurements
group Id
BG000
value
12
group Id
BG001
value
15
group Id
BG002
value
27
title
Unknown or Not Reported
param Type
COUNT_OF_PARTICIPANTS
title
Ethnicity (NIH/OMB)
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
380
group Id
BG001
value
367
group Id
BG002
value
747
title
White
categories
measurements
group Id
BG000
value
17
group Id
BG001
value
19
group Id
BG002
value
36
title
Black
categories
measurements
group Id
BG000
value
2
group Id
BG001
value
8
group Id
BG002
value
10
title
Other
categories
measurements
group Id
BG000
value
7
group Id
BG001
value
5
group Id
BG002
value
12
title
Unknown
param Type
COUNT_OF_PARTICIPANTS
title
Race/Ethnicity, Customized
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
295
group Id
BG001
value
300
group Id
BG002
value
595
title
0
categories
measurements
group Id
BG000
value
111
group Id
BG001
value
99
group Id
BG002
value
210
title
1
description
Measure Description: 0 - Asymptomatic; 1 - Symptomatic but completely ambulatory; 2 - Symptomatic, \<50% in bed during the day; 3 - Symptomatic, \>50% in bed, but not bedbound; 4 - Bedbound; 5 - Death
param Type
COUNT_OF_PARTICIPANTS
title
Zubrod performance status
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
194
group Id
BG001
value
181
group Id
BG002
value
375
title
0 pack-years
categories
measurements
group Id
BG000
value
59
group Id
BG001
value
68
group Id
BG002
value
127
title
>0 to <= 10 pack-years
categories
measurements
group Id
BG000
value
153
group Id
BG001
value
150
group Id
BG002
value
303
title
>10 pack-years
description
Smoking history as measured in pack-years. It is calculated by multiplying the number of packs of cigarettes smoked per day by the number of years the person has smoked.
param Type
COUNT_OF_PARTICIPANTS
title
Smoking history
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
lower Limit
0
upper Limit
22
value
2
group Id
BG001
lower Limit
0
upper Limit
24
value
3
group Id
BG002
lower Limit
0
upper Limit
23
value
2
description
Measure Description: Smoking history as measured in pack-years. It is calculated by multiplying the number of packs of cigarettes smoked per day by the number of years the person has smoked.
dispersion Type
INTER_QUARTILE_RANGE
param Type
MEDIAN
title
Smoking history
unit Of Measure
pack-years
classes
categories
measurements
group Id
BG000
value
202
group Id
BG001
value
199
group Id
BG002
value
401
title
Tonsillar fossa, tonsil
categories
measurements
group Id
BG000
value
174
group Id
BG001
value
179
group Id
BG002
value
353
title
Base of tongue
categories
measurements
group Id
BG000
value
16
group Id
BG001
value
15
group Id
BG002
value
31
title
Oropharynx, not otherwise specified
categories
measurements
group Id
BG000
value
8
group Id
BG001
value
5
group Id
BG002
value
13
title
Pharyngeal oropharynx
categories
measurements
group Id
BG000
value
4
group Id
BG001
value
0
group Id
BG002
value
4
title
Soft palate
categories
measurements
group Id
BG000
value
2
group Id
BG001
value
1
group Id
BG002
value
3
title
Vallecula
description
Primary location of tumor
param Type
COUNT_OF_PARTICIPANTS
title
Primary site
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
89
group Id
BG001
value
86
group Id
BG002
value
175
title
T1
categories
measurements
group Id
BG000
value
162
group Id
BG001
value
163
group Id
BG002
value
325
title
T2
categories
measurements
group Id
BG000
value
108
group Id
BG001
value
100
group Id
BG002
value
208
title
T3
categories
measurements
group Id
BG000
value
47
group Id
BG001
value
50
group Id
BG002
value
97
title
T4
description
Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues.
param Type
COUNT_OF_PARTICIPANTS
title
Tumor stage
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
20
group Id
BG001
value
14
group Id
BG002
value
34
title
N0
categories
measurements
group Id
BG000
value
20
group Id
BG001
value
25
group Id
BG002
value
45
title
N1
categories
measurements
group Id
BG000
value
59
group Id
BG001
value
56
group Id
BG002
value
115
title
N2a
categories
measurements
group Id
BG000
value
209
group Id
BG001
value
208
group Id
BG002
value
417
title
N2b
categories
measurements
group Id
BG000
value
82
group Id
BG001
value
83
group Id
BG002
value
165
title
N2c
categories
measurements
group Id
BG000
value
16
group Id
BG001
value
13
group Id
BG002
value
29
title
N3
description
Regional lymph nodes staging per American Joint Committee on Cancer (AJCC) 7th ed. refers to the number and/or extent of spread of lymph nodes that contain cancer. The higher the number after the N, the greater the involvement of regional lymph nodes.
param Type
COUNT_OF_PARTICIPANTS
title
Node category
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
29
group Id
BG001
value
31
group Id
BG002
value
60
title
III
measurements
group Id
BG000
value
377
group Id
BG001
value
368
group Id
BG002
value
745
title
IV
description
Overall cancer stage per American Joint Committee on Cancer (AJCC) 7th ed. combines tumor (T), regional lymph node (N), and distant metastasis (M) staging to determine an overall stage of 0, I, II, III, or IV, ranging from least to most advanced, respectively. Stage III: T3/N0/M0 or T1-3/N1/M0; Stage IV: T4/any N/M0 or any T/N2-3/M0.
param Type
COUNT_OF_PARTICIPANTS
title
Overall stage
unit Of Measure
Participants

population Description

Eligible participants

Complete source fields

denoms

counts
group Id
BG000
value
406
group Id
BG001
value
399
group Id
BG002
value
805
units
Participants

groups

description
Intensity-modulated radiotherapy (IMRT) with concurrent cisplatin Cisplatin: 100 mg/m2 IV on days 1 and 22 of IMRT IMRT: 35 fractions over 6 weeks, 6 fractions per week, 2 Gray per fraction to total dose of 70 Gy.
id
BG000
title
IMRT + Cisplatin
description
Intensity-modulated radiotherapy (IMRT) with concurrent cetuximab Cetuximab: 400 mg/m2 IV 5-7 days before IMRT then 250 mg/m2 IV weekly for 7 weeks IMRT: 35 fractions over 6 weeks, 6 fractions per week, 2 Gray per fraction to total dose of 70 Gy.
id
BG001
title
IMRT + Cetuximab
description
Total of all reporting groups
id
BG002
title
Total

measures

classes
categories
measurements
group Id
BG000
lower Limit
52
upper Limit
63
value
58
group Id
BG001
lower Limit
52
upper Limit
63
value
58
group Id
BG002
lower Limit
52
upper Limit
63
value
58
dispersion Type
INTER_QUARTILE_RANGE
param Type
MEDIAN
title
Age, Continuous
unit Of Measure
years
classes
categories
measurements
group Id
BG000
value
344
group Id
BG001
value
345
group Id
BG002
value
689
title
<= 65
categories
measurements
group Id
BG000
value
62
group Id
BG001
value
54
group Id
BG002
value
116
title
> 65
param Type
COUNT_OF_PARTICIPANTS
title
Age, Customized
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
33
group Id
BG001
value
44
group Id
BG002
value
77
title
Female
measurements
group Id
BG000
value
373
group Id
BG001
value
355
group Id
BG002
value
728
title
Male
param Type
COUNT_OF_PARTICIPANTS
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
11
group Id
BG001
value
15
group Id
BG002
value
26
title
Hispanic or Latino
measurements
group Id
BG000
value
383
group Id
BG001
value
369
group Id
BG002
value
752
title
Not Hispanic or Latino
measurements
group Id
BG000
value
12
group Id
BG001
value
15
group Id
BG002
value
27
title
Unknown or Not Reported
param Type
COUNT_OF_PARTICIPANTS
title
Ethnicity (NIH/OMB)
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
380
group Id
BG001
value
367
group Id
BG002
value
747
title
White
categories
measurements
group Id
BG000
value
17
group Id
BG001
value
19
group Id
BG002
value
36
title
Black
categories
measurements
group Id
BG000
value
2
group Id
BG001
value
8
group Id
BG002
value
10
title
Other
categories
measurements
group Id
BG000
value
7
group Id
BG001
value
5
group Id
BG002
value
12
title
Unknown
param Type
COUNT_OF_PARTICIPANTS
title
Race/Ethnicity, Customized
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
295
group Id
BG001
value
300
group Id
BG002
value
595
title
0
categories
measurements
group Id
BG000
value
111
group Id
BG001
value
99
group Id
BG002
value
210
title
1
description
Measure Description: 0 - Asymptomatic; 1 - Symptomatic but completely ambulatory; 2 - Symptomatic, \<50% in bed during the day; 3 - Symptomatic, \>50% in bed, but not bedbound; 4 - Bedbound; 5 - Death
param Type
COUNT_OF_PARTICIPANTS
title
Zubrod performance status
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
194
group Id
BG001
value
181
group Id
BG002
value
375
title
0 pack-years
categories
measurements
group Id
BG000
value
59
group Id
BG001
value
68
group Id
BG002
value
127
title
>0 to <= 10 pack-years
categories
measurements
group Id
BG000
value
153
group Id
BG001
value
150
group Id
BG002
value
303
title
>10 pack-years
description
Smoking history as measured in pack-years. It is calculated by multiplying the number of packs of cigarettes smoked per day by the number of years the person has smoked.
param Type
COUNT_OF_PARTICIPANTS
title
Smoking history
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
lower Limit
0
upper Limit
22
value
2
group Id
BG001
lower Limit
0
upper Limit
24
value
3
group Id
BG002
lower Limit
0
upper Limit
23
value
2
description
Measure Description: Smoking history as measured in pack-years. It is calculated by multiplying the number of packs of cigarettes smoked per day by the number of years the person has smoked.
dispersion Type
INTER_QUARTILE_RANGE
param Type
MEDIAN
title
Smoking history
unit Of Measure
pack-years
classes
categories
measurements
group Id
BG000
value
202
group Id
BG001
value
199
group Id
BG002
value
401
title
Tonsillar fossa, tonsil
categories
measurements
group Id
BG000
value
174
group Id
BG001
value
179
group Id
BG002
value
353
title
Base of tongue
categories
measurements
group Id
BG000
value
16
group Id
BG001
value
15
group Id
BG002
value
31
title
Oropharynx, not otherwise specified
categories
measurements
group Id
BG000
value
8
group Id
BG001
value
5
group Id
BG002
value
13
title
Pharyngeal oropharynx
categories
measurements
group Id
BG000
value
4
group Id
BG001
value
0
group Id
BG002
value
4
title
Soft palate
categories
measurements
group Id
BG000
value
2
group Id
BG001
value
1
group Id
BG002
value
3
title
Vallecula
description
Primary location of tumor
param Type
COUNT_OF_PARTICIPANTS
title
Primary site
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
89
group Id
BG001
value
86
group Id
BG002
value
175
title
T1
categories
measurements
group Id
BG000
value
162
group Id
BG001
value
163
group Id
BG002
value
325
title
T2
categories
measurements
group Id
BG000
value
108
group Id
BG001
value
100
group Id
BG002
value
208
title
T3
categories
measurements
group Id
BG000
value
47
group Id
BG001
value
50
group Id
BG002
value
97
title
T4
description
Tumor stage per the American Joint Committee on Cancer (AJCC) 7th ed. refers to the size and/or extent of the main tumor. The higher the number after the T, the larger the tumor or the more it has grown into nearby tissues.
param Type
COUNT_OF_PARTICIPANTS
title
Tumor stage
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
20
group Id
BG001
value
14
group Id
BG002
value
34
title
N0
categories
measurements
group Id
BG000
value
20
group Id
BG001
value
25
group Id
BG002
value
45
title
N1
categories
measurements
group Id
BG000
value
59
group Id
BG001
value
56
group Id
BG002
value
115
title
N2a
categories
measurements
group Id
BG000
value
209
group Id
BG001
value
208
group Id
BG002
value
417
title
N2b
categories
measurements
group Id
BG000
value
82
group Id
BG001
value
83
group Id
BG002
value
165
title
N2c
categories
measurements
group Id
BG000
value
16
group Id
BG001
value
13
group Id
BG002
value
29
title
N3
description
Regional lymph nodes staging per American Joint Committee on Cancer (AJCC) 7th ed. refers to the number and/or extent of spread of lymph nodes that contain cancer. The higher the number after the N, the greater the involvement of regional lymph nodes.
param Type
COUNT_OF_PARTICIPANTS
title
Node category
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
29
group Id
BG001
value
31
group Id
BG002
value
60
title
III
measurements
group Id
BG000
value
377
group Id
BG001
value
368
group Id
BG002
value
745
title
IV
description
Overall cancer stage per American Joint Committee on Cancer (AJCC) 7th ed. combines tumor (T), regional lymph node (N), and distant metastasis (M) staging to determine an overall stage of 0, I, II, III, or IV, ranging from least to most advanced, respectively. Stage III: T3/N0/M0 or T1-3/N1/M0; Stage IV: T4/any N/M0 or any T/N2-3/M0.
param Type
COUNT_OF_PARTICIPANTS
title
Overall stage
unit Of Measure
Participants

population Description

Eligible participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice